School patents method using umbilical cord-blood cells

07/9/2010 | American City Business Journals

The University of South Florida's department of neurosurgery and brain repair has received a patent for a cell transplantation method that uses human umbilical cord-blood cells in combination with a compound called mannitol to treat neurodegenerative diseases. Saneron CCEL Therapeutics, a biotech research and development company, has licensed the technology.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN